Patrick W. McGarrah

466 total citations
31 papers, 273 citations indexed

About

Patrick W. McGarrah is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Patrick W. McGarrah has authored 31 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 18 papers in Epidemiology and 12 papers in Neurology. Recurrent topics in Patrick W. McGarrah's work include Neuroendocrine Tumor Research Advances (16 papers), Lung Cancer Research Studies (15 papers) and Neuroblastoma Research and Treatments (12 papers). Patrick W. McGarrah is often cited by papers focused on Neuroendocrine Tumor Research Advances (16 papers), Lung Cancer Research Studies (15 papers) and Neuroblastoma Research and Treatments (12 papers). Patrick W. McGarrah collaborates with scholars based in United States, Australia and Canada. Patrick W. McGarrah's co-authors include Þorvarður R. Hálfdánarson, A. Tuba Kendi, Timothy J. Hobday, Kezban Berberoğlu, Jason S. Starr, Annie T. Packard, Carrie B. Hruska, David J. Bartlett, Derek R. Johnson and Mohamad Bassam Sonbol and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Patrick W. McGarrah

25 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick W. McGarrah United States 9 166 127 92 44 34 31 273
Cynthia McCully United States 8 86 0.5× 21 0.2× 23 0.3× 75 1.7× 10 0.3× 19 256
Astrid Capello Netherlands 14 175 1.1× 156 1.2× 85 0.9× 90 2.0× 172 5.1× 17 417
H Friess Germany 6 205 1.2× 46 0.4× 9 0.1× 180 4.1× 50 1.5× 8 391
E Bork Denmark 11 279 1.7× 120 0.9× 34 0.4× 153 3.5× 14 0.4× 17 460
Maria Luisa Tamma Switzerland 6 186 1.1× 140 1.1× 41 0.4× 41 0.9× 237 7.0× 7 335
Véronique Eltschinger Switzerland 7 220 1.3× 258 2.0× 109 1.2× 82 1.9× 176 5.2× 7 385
Barbara Janota Poland 8 196 1.2× 234 1.8× 117 1.3× 25 0.6× 115 3.4× 16 319
David J. Voce United States 10 48 0.3× 61 0.5× 48 0.5× 191 4.3× 20 0.6× 13 395
Inge R. Konings Netherlands 5 76 0.5× 53 0.4× 24 0.3× 22 0.5× 75 2.2× 14 196

Countries citing papers authored by Patrick W. McGarrah

Since Specialization
Citations

This map shows the geographic impact of Patrick W. McGarrah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick W. McGarrah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick W. McGarrah more than expected).

Fields of papers citing papers by Patrick W. McGarrah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick W. McGarrah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick W. McGarrah. The network helps show where Patrick W. McGarrah may publish in the future.

Co-authorship network of co-authors of Patrick W. McGarrah

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick W. McGarrah. A scholar is included among the top collaborators of Patrick W. McGarrah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick W. McGarrah. Patrick W. McGarrah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuentes, Harry E, et al.. (2025). CDX2 expression as a predictive and prognostic biomarker of 5-FU response in cancer of unknown primary. ESMO Open. 10(8). 105515–105515.
2.
Whaley, Rumeal D., Patrick W. McGarrah, Mauricio E. Gamez, et al.. (2024). Oropharyngeal mucoepidermoid carcinoma: A systematic review of the literature. SHILAP Revista de lepidopterología. 13. 100695–100695.
3.
Rosenberg, Ari J., et al.. (2024). Breaking Ground in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Novel Therapies Beyond PD-L1 Immunotherapy. American Society of Clinical Oncology Educational Book. 44(3). e433330–e433330. 5 indexed citations
4.
Smith, Katherine E., Surendra Dasari, Wasantha Ranatunga, et al.. (2024). Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK Alterations. JCO Precision Oncology. 8(8). e2400471–e2400471. 2 indexed citations
5.
McGarrah, Patrick W., et al.. (2024). Alpelisib and Immunotherapy: A Promising Combination for Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck. Cancer Reports. 7(10). e70023–e70023. 3 indexed citations
6.
McGarrah, Patrick W., Shruthi Naik, Þorvarður R. Hálfdánarson, et al.. (2024). Phase 1/2 trial of vesicular stomatitis virus expressing human interferon-β and NIS (VSV-IFNβ-NIS), with ipilimumab and nivolumab, in patients with neuroendocrine carcinoma.. Journal of Clinical Oncology. 42(3_suppl). TPS602–TPS602. 1 indexed citations
7.
McGarrah, Patrick W., Joleen M. Hubbard, Paul J. Novotny, et al.. (2023). Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer. Cancer Control. 30. 2915603095–2915603095. 3 indexed citations
8.
McGarrah, Patrick W., Alan Paciorek, Amr Mohamed, et al.. (2023). Urinary Neuroendocrine Neoplasms Treated in the “Modern Era”: A Multicenter Retrospective Review. Clinical Genitourinary Cancer. 21(3). 403–414.e5. 5 indexed citations
9.
10.
Gile, Jennifer, Patrick W. McGarrah, Konstantinos Leventakos, et al.. (2023). Efficacy of first‐line checkpoint inhibitors in combination with chemotherapy in high‐grade extrapulmonary metastatic neuroendocrine carcinomas. Journal of Neuroendocrinology. 35(5). e13283–e13283. 1 indexed citations
11.
Chintakuntlawar, Ashish V., et al.. (2023). Capecitabine for Salvage Treatment of Patients With Heavily Pretreated Human Papillomavirus–Associated Oropharynx Cancer With Distant Metastases. Journal of the Advanced Practitioner in Oncology. 14(7). 571–575.
12.
Andreatos, Nikolaos, Patrick W. McGarrah, Mohamad Bassam Sonbol, et al.. (2023). Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment. Current Oncology Reports. 25(10). 1127–1139.
13.
Desai, Aakash, Þorvarður R. Hálfdánarson, Steven R. Alberts, et al.. (2022). KRAS wild-type pancreatic ductal adenocarcinoma: Molecular and therapeutic opportunities.. Journal of Clinical Oncology. 40(16_suppl). 4130–4130. 1 indexed citations
14.
McGarrah, Patrick W., Horatiu Olteanu, Daniel L. Van Dyke, et al.. (2021). Utilizing next-generation sequencing to characterize a case of acute myeloid leukemia with t(4;12)(q12;p13) in the absence of ETV6/CHIC2 and ETV6/PDGFRA gene fusions. Cancer Genetics. 260-261. 1–5. 2 indexed citations
15.
Gile, Jennifer, Patrick W. McGarrah, Timothy J. Hobday, et al.. (2021). Efficacy of Checkpoint Inhibitors in Neuroendocrine Neoplasms. Pancreas. 50(4). 500–505. 11 indexed citations
16.
McGarrah, Patrick W., A. Tuba Kendi, Jason S. Starr, et al.. (2021). Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors. The Oncologist. 26(5). 383–388. 29 indexed citations
17.
McGarrah, Patrick W., Konstantinos Leventakos, Timothy J. Hobday, et al.. (2020). Efficacy of Second-Line Chemotherapy in Extrapulmonary Neuroendocrine Carcinoma. Pancreas. 49(4). 529–533. 17 indexed citations
18.
McGarrah, Patrick W., et al.. (2019). Renal Neuroendocrine Neoplasms: A Single-center Experience. Clinical Genitourinary Cancer. 18(4). e343–e349. 13 indexed citations
19.
Guo, Zhijun, et al.. (2018). Targeting cytochrome P450-dependent cancer cell mitochondria: cancer associated CYPs and where to find them. Cancer and Metastasis Reviews. 37(2-3). 409–423. 31 indexed citations
20.
Kibaly, Cherkaouia, Yujun Wang, Chi Xu, et al.. (2017). Src‐dependent phosphorylation of μ‐opioid receptor at Tyr 336 modulates opiate withdrawal. EMBO Molecular Medicine. 9(11). 1521–1536. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cynthia McCully Breakdown of academic impact, for papers by Astrid Capello Breakdown of academic impact, for papers by H Friess Breakdown of academic impact, for papers by E Bork Breakdown of academic impact, for papers by Maria Luisa Tamma Breakdown of academic impact, for papers by Véronique Eltschinger Breakdown of academic impact, for papers by Barbara Janota Breakdown of academic impact, for papers by David J. Voce Breakdown of academic impact, for papers by Inge R. Konings
Rankless by CCL
2026